Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication

ANZ Journal of Surgery

Volumn 72, Issue 12, 2002, Pages 917-919

  Rai, Rakesh ^a   Rai, Sundeepa ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b CROSSHOUSE HOSPITAL   (United Kingdom)

Author keywords

Clostridium difficile; Helicobacter pylori; Pseudomembranous colitis

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; COLOSTOMY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; ENDOSCOPY; ERADICATION THERAPY; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; LAPAROTOMY; LARGE INTESTINE; MALE; PATIENT REFERRAL; PERITONITIS; PSEUDOMEMBRANOUS COLITIS; PULSE RATE; SIGMOIDOSCOPY; SURGICAL TECHNIQUE; TACHYCARDIA; TIME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; OMEPRAZOLE;

EID: 0036908117     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2002.02593.x     Document Type: Article

References (22)

1. Malfertheiner P, Megraud F, O'Morain C et al. Current European concepts in the management of Helicobacter pylori infection - The Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur. J. Gastroenterol. Hepatol. 1997; 9: 1-2.
2. Archimandritis A, Souyioultzis M, Katsorida M, Tzivras M. Clostridium difficile colitis associated with a 'triple' regimen, containing clarthromycin and metronidazole, to eradicate Helicobacter pylori. J. Intern. Med. 1998; 243: 251-3.
3. Nawaz A, Mohammed I, Ahsan K, Karakurum A, Hadjiyane C, Pellechia C.Clostrididium difficile colitis associated with treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 1998; 93: 1175-7.
4. Settle CD, Wilcox MH. Review article: Antibiotic-induced Clostridium difficile infection. Aliment. Pharmacol. Ther. 1996; 10: 835-41.
5. Reinke CM, Messick CR. Update on Clostridium difficile colitis, Part 1. Am. J. Hosp. Pharm. 1994; 51: 1771-81.
6. Samore MH, Bettin KM, DeGirolami PC, Clabots CR, Gerding DN, Karchmer AW. Wide diversity of Clostridium difficile types at a tertiary referral hospital. J. Infect. Dis. 1994; 170: 615-21.
7. Mcfarland LV, Mulligan ME, Kwok RYY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 1989; 320: 204-10.
8. Tedesco FJ, Anderson CB, Ballinger WF. Drug induced colitis mimicking an acute surgical condition of the abdomen. Arch. Surg. 1975; 110: 481-4.
9. Triadafiopoulos G, Hallstone AE. Acute abdomen as the first presentation of pseudomembranous colitis. Gastroenterology 1991; 101: 685-91.
10. Teare JP, Booth CL, Brown JL, Martin J, Thomas HC. Pseudomembranous colitis following clarithromycin therapy. Eur. J. Gatstrenterol. Hepatol. 1995; 7: 275-7.
11. Lau CF, Hui PK, Fung TT et al. Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy. Hosp. Med. 2001; 62: 431-3.
12. Harsch IA, Hahn EG, Konturek PC. Pseudomembranous colitis after eradication of Helicobacter pylori infection with a triple therapy. Med. Sci. Monit. 2001; 7: 751-4.
13. Roseveare CD, Van Heel DA, Arthur MJ, Lawrance RJ. Helicobacter pylori: Beware 'blind' eradication! Gut 1998; 42: 757.
14. Awad RW, Ward KL, Hawker PC. Fulminant pseudomembranous colitis (PMC) following triple therapy for Helicobacter pylori. J. R. Coll. Surg. Edinb. 1994; 39: 319.
15. Olson MM, Shanholtzer CJ, Lee JT Jr, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect. Control Hosp. Epidemiol. 1994; 15: 371-81.
16. Teasley DG, Gerding DN, Olson MM et al. Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet 1983; 2: 1043-6.
17. Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin. Infect. Dis. 1996; 22: 813-18.
18. Anon. ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile-associated disease. Am. J. Health Syst. Pharm. 1998; 55: 1407-11.
19. Guzman R, Kirkpatrick J, Forward K, Lim F. Failure of parenteral metronidazole in the treatment of pseudomembranous colitis [letter]. J. Infect. Dis. 1988; 158: 1146-7.
20. Oliva SL, Guglielmo BJ, Jacobs R, Pons VG. Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis [letter]. J. Infect. Dis. 1989; 159: 1154-5.
21. Fekety R. Guidelines for diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology Practice Parameters Committee. Am. J. Gastroenterol. 1997; 92: 739-50.
22. Bradbury AW, Barret S. Surgical aspects of Clostridium difficile colitis. Br. J. Surg. 1997; 84: 150-9.